Cosmo First Targets 15–20% ROCE, All B2B Profitable

Cosmo First Limited — Q1 FY27 Earnings Call (held Aug 07, 2026; results for June 2026 quarter)

1. Overall Tone of Management: Optimistic

• Management highlights “continued momentum” and that “all our B2B businesses are now profitable.”
• They emphasize a transition from capex to value creation: “major phase of our capital investment behind us” and focus on “improving returns on capital employed and strengthening cash generation.”
• Guidance is provided with confidence (e.g., “expects topline to grow by about 20% in FY26-27”).

2. Key Themes from Management Commentary

• B2B profitability + scaling: “all our B2B businesses are now profitable,” with EBITDA up 26% YoY to ₹147 cr despite export volume suppression from port congestion.
• Specialty mix as the margin engine: Specialty film margins described as stable (“Rs 63 per kg”), and management repeatedly ties ROCE improvement to shifting mix toward specialty/semi-specialty.
• US tariff normalization as a tailwind: US tariffs reduced; they cite “post reduction in the USA tariffs” and a USD ~7m refund (cash impact pending customer refund adjustments).
• Capex cycle largely complete; ROCE/cash focus next: “Capex cycle… largely complete” and FY27 focus is “leveraging these assets” to improve ROCE and cash generation.
• New businesses scaling with limited incremental capex: Specialty chemicals, rigid packaging (Plastech), and consumer businesses are scaling; Plastech capacity growth planned “with minimal capex.”
• Debt reduction roadmap: Net debt flat QoQ but management reiterates a “clear roadmap to reduce net debt over next 2 years,” targeting net debt/EBITDA <2x in ~12 months.

3. Q&A Analysis

Theme A: ROCE improvement & capital allocation levers

• Core questions
• How ROCE will move from ~8–11% (recent years) to 15–20% over 12–24 months?
• Business-by-business growth/profitability levers.
• Management response
• Explicit ROCE target: “take it to anywhere between 15% to 20%.”
• Levers: volume growth from spare capacity (“15% more capacity… film business”), specialty mix improvement, and scaling B2C/B2B with “minimal capex.”
• Growth expectations: “overall… revenue should grow by minimum 20%… new businesses… 60%.”
• Notable/strong points
• They quantify specialty margin uplift: semi-specialty “Rs 15 to Rs 20 higher” than base; specialty “Rs 60 plus for 5 quarters.”
• They provide a structured ROCE narrative (volume + mix + asset sweating + debt reduction).

Theme B: Film margins (BOPP/BOPET) sustainability & raw material pass-through

• Core questions
• Why margins lagged revenue growth (revenue +46% vs EBITDA margin down in % terms)?
• Whether raw material price increases are passed through; outlook for BOPP/BOPET margins sequentially.
• Management response
• Explains denominator effect: raw material pass-through inflates revenue and margin ratio; “right margin is contribution per kilogram.”
• Sustainability: structural drivers (specialty mix, US tariff benefit, specialty chemicals, positive plastic EBITDA), but admits one-time element: “element due to inventory gain… is one time and market dependent.”
• BOPET outlook: expects improvement due to “anti-dumping duty… levied recently” and overcapacity correction.
• Evasive/partial elements
• They avoid giving a precise forward margin number; instead they discuss directional expectations and structural vs one-time components.

Theme C: Specialty mix targets vs capacity constraints

• Core questions
• How to reach specialty mix ~90% (or 70%+) given only ~15% spare capacity?
• Specialty product development progress and differentiation.
• Management response
• Clarifies capacity headroom: “no capacity constraints… target is anyways to keep improving the mix.”
• Mix trajectory: current mix “61%” (highest in last five quarters); objective “move it to 70%.”
• Product development: launched multiple specialty SKUs in the quarter; patents “6 granted and 11 in pipeline.”
• Notable
• They reconcile apparent contradiction by emphasizing reallocation of existing capacity to specialty rather than relying solely on incremental tonnage.

Theme D: Rigid packaging (Plastech) growth plan & profitability path

• Core questions
• Medium-term plan for rigid packaging; revenue and margin trajectory.
• Capacity utilization and whether margins improve.
• Management response
• Quantified ramp: last year ~₹100 cr → FY27 target ₹150–160 cr, next year ₹200+ cr.
• Profitability: turned EBITDA positive; FY27 focus on “higher profitability through higher capacity utilisation, improving sales mix and improved efficiency.”
• Capacity utilization: film business 85% in June quarter; Plastech described as 100% utilization in Q&A (with some back-and-forth).
• Potential inconsistency
• Utilization discussion had minor confusion (“utilization is 100%” then clarification), but management still maintained the growth/margin roadmap.

Theme E: Consumer businesses (Zigly & Cosmo Consumer) breakeven and guidance

• Core questions
• When Zigly breaks even (PAT/EBITDA) and what drives losses narrowing.
• Cosmo Consumer breakeven level and margin floors.
• Management response
• Zigly: “breakeven should happen around Rs. 250 crores of revenue” (EBITDA perspective), and “still going to take a couple of years.”
• Zigly Q1 loss widened to ~₹15 cr due to “invest[ing] ahead of revenue” (retail centers, acquisitions, private label launches).
• Cosmo Consumer: breakeven “even earlier than Rs. 100 crores,” and gross margins expected 35–40% as it scales.
• They provide unit-economics signals (gross margin ~47%, services/private label mix shift, repeat customers).
• Strong admissions
• They explicitly state profitability timing uncertainty: Zigly “couple of years.”

Theme F: Debt reduction, capex, and renewable savings timing

• Core questions
• Whether net debt/EBITDA target relies on EBITDA growth vs debt repayment.
• Renewable energy savings—when they actually kick in.
• Management response
• Both: already reduced net debt ~₹70 cr despite working capital increase; expects further reduction ₹400–500 cr over two years.
• Renewable savings: “yet to kick in,” with one project expected from Q3 and another from Q1 next year; “in Quarter 1 FY27, nothing is baked in.”
• Credibility-positive
• They correct/qualify timing rather than implying savings already realized.

Theme G: Export volume decline vs US traction

• Core questions
• Why export volumes were down (port congestion, in-transit booking) despite “good US traction.”
• Management response
• Port/logistics explanation: in-transit volume higher due to disturbances; some volume not booked as sales until bill of lading prepared.
• Also mentions one line maintenance and normalization expectations for Q2.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY26–27 topline: “about 20%” growth on overall basis.
• FY26–27 bottom-line: “commensurate increase” (no numeric).
• New businesses growth: “four new businesses… expected to grow about 60%.”
• US subsidiary growth (this year): “25% to 30%” post duty rationalization.
• ROCE target: “15% to 20%” over next 12–24 months.
• Net debt/EBITDA: expects to reduce to “below 2 times… in next 12 months.”
• Rigid packaging (Plastech) revenue:
• FY27: “₹150–160 cr” (from ~₹100 cr last year)
• Next year: “₹200+ cr”
• Zigly breakeven (qualitative threshold with number):
• “around Rs. 250 crores of revenue” (EBITDA breakeven)
• Cosmo Consumer breakeven:
• “even earlier than Rs. 100 crores”
• Specialty chemicals medium-term acceleration:
• FY30 target (from prior narrative) questioned; management says “good likelihood that by FY ’29 itself, we will surpass this target.”
• Debt reduction (quantitative): “reasonable reduction of Rs. 400 crores to Rs. 500 crores” over next two years.

Implicit signals (qualitative)

• Margins: structural support from specialty mix, US tariff benefit, specialty chemicals, and positive plastic EBITDA; but acknowledges one-time inventory gain and commodity volatility.
• BOPET: expects improvement due to anti-dumping duty and overcapacity correction.
• Capex: “capex cycle… largely complete” and “containing any significant Capex” (debt reduction narrative depends on this).
• Demand: “demand is quite strong” (for films) and management expects recovery of export volumes as port situation normalizes.

5. Standout Statements (direct / high-signal)

• “All our B2B businesses are now profitable.”
• “Capex cycle… largely complete. Now… focused on leveraging these assets, improving returns on capital employed and strengthening cash generation.”
• “We intend to take [ROCE] to anywhere between 15% to 20%.”
• “The Company expects topline to grow by about 20% in FY26-27…”
• “Further four new businesses are expected to grow about 60%.”
• Margin sustainability caveat: “element due to inventory gain… is one time and market dependent.”
• BOPET direction: “with the anti-dumping duty… we expect that the BOPET margins should go up.”
• Debt target: “net debt to EBITDA to reduce to below 2 times… in next 12 months.”
• Renewable savings timing correction: “Renewable power projected savings are yet to kick in… in Quarter 1 FY27, nothing is baked in.”
• Zigly breakeven threshold: “Zigly breakeven should happen around Rs. 250 crores of revenue.”

6. Red Flags / Positive Signals

Red flags
– Margin volatility acknowledged repeatedly; limited forward margin quantification.
– One-time items explicitly referenced (inventory gain in base BOPP margin).
– Zigly losses still active; management admits profitability timing “couple of years.”
– Port congestion / in-transit booking affects volume comparability (possible noise in export performance metrics).

Positive signals
– Clear transition from capex to ROCE + cash generation.
– B2B profitability achieved (“all B2B businesses are now profitable”).
– Quantified ROCE and debt targets with timelines.
– Specialty margin stability claim (specialty “Rs 60 plus” for multiple quarters).
– Renewable savings timing is transparently qualified (reduces risk of overstatement).

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• More Optimistic vs earlier calls (Nov 2025 / Feb 2026 / May 2026).
• Earlier tone emphasized ramp-up and volatility; now management stresses profitability across B2B and a post-capex phase.
• They still hedge on commodity margins, but overall confidence in scaling and ROCE is stronger.

b. Tracking Past Commitments vs Outcomes

• Capex cycle largely complete / sweating assets
• Prior (Feb 2026): “Capex cycle… largely complete… sweating strategic capex.”
• Current (Aug 2026): reiterates “major phase… behind us.” ✅ Consistent / Delivered narrative
• Plastech reaching EBITDA breakeven
• Prior (May 2026): “Rigid packaging… reached EBITDA-breakeven.”
• Current (Aug 2026): “turned EBITDA positive (7%)” and scaling plan. ✅ Delivered / improved
• Zigly demerger timeline
• Prior (Nov 2025): demerger plan “by March’27” and “deadline couple of years back.”
• Current (Aug 2026): not reiterated as a commitment in this call, but Zigly profitability timeline is discussed. ⏳ Not dropped, but less emphasized
• Debt reduction roadmap
• Prior (May 2026): net debt reduction roadmap; debt reduced by ~₹75 cr in 6 months.
• Current: net debt flat QoQ but expects ₹400–500 cr reduction over two years and <2x in 12 months. ✅/⏳ On track directionally; timing depends on execution
• Specialty mix targets
• Prior (Feb 2026): specialty as % volume temporarily down due to new capacities; target to recover to ~70% in “a couple of years.”
• Current: specialty mix now “61%” and objective “move it to 70%.” ✅ Consistent trajectory, though still not at target.

c. Narrative Shifts

• From ramp-up to ROCE/cash: Earlier calls focused on commissioning/ramp and tariff impacts; current call emphasizes ROCE improvement and cash generation.
• Margin story refined: They now more explicitly separate contribution per kg vs EBITDA margin ratio effects (raw material pass-through inflating revenue denominator).
• Consumer business framing matured: More concrete breakeven thresholds and unit-economics metrics (gross margin ~47%, repeat customers, private label growth).

d. Consistency & Credibility Signals

• Medium-to-High credibility:
• They provide clearer quantified targets (ROCE 15–20%, topline +20%, net debt/EBITDA <2x).
• They acknowledge one-time effects and qualify renewable savings timing (“nothing baked in”).
• Still some credibility risk:
• Commodity margin direction is repeatedly “expected to go up” without firm numbers.
• Export volume explanations rely on logistics/in-transit booking, which can obscure underlying demand.

e. Evolution of Key Themes

• Demand: “strong demand” now stated more directly; earlier calls discussed demand-supply balance and volatility.
• Margins: shift from “volatile/forecast difficult” to “structural support exists,” but still with caveats (inventory gain, BOPET overcapacity).
• Expansion: rigid packaging and specialty chemicals move from breakeven/ramp to scaling with minimal capex.
• Debt/capital: consistent theme of capex completion and debt reduction; current call adds more explicit net debt/EBITDA timeline.

f. Additional Insights (cross-period)

• Inventory gain vs sustainability: Earlier calls discussed inventory effects (inventory gain/loss). Current call again flags inventory gain as one-time—suggesting management is aware that margin improvements may not fully repeat.
• Specialty margin stability claim strengthened: Management now asserts specialty margins “Rs 60 plus for all these 5 quarters,” indicating a more stable value proposition than commodity films.
• Renewables savings timing risk reduced: By stating savings “yet to kick in,” management reduces the chance that future results disappoint due to assumed cost benefits already realized.